Search

Search Constraints

You searched for: Author/Creator Banerji, Aleena

Search Results

2. Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study. Issue 10 (5th July 2021)

5. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence. Issue 8 (27th April 2020)

6. Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study. Issue 4 (24th December 2020)

7. The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update. Issue 7 (3rd February 2022)

8. Symptom monitoring after coronavirus disease 2019 (COVID-19) vaccination in a large integrated healthcare system: Separating symptoms from severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection. (2nd October 2022)

10. Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks. Issue 11 (6th July 2020)